Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
12.49
+0.62 (5.22%)
Nov 22, 2024, 4:00 PM EST - Market closed
Mineralys Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$30.00
Upside
+140.19%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +140.19% | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +140.19% | Oct 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +140.19% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +140.19% | Jul 10, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +140.19% | Apr 2, 2024 |
| Credit Suisse | Credit Suisse | Buy Maintains $38 → $37 | Buy | Maintains | $38 → $37 | +196.24% | Aug 8, 2023 |
| Credit Suisse | Credit Suisse | Buy Reiterates $38 | Buy | Reiterates | $38 | +204.24% | May 16, 2023 |
| Credit Suisse | Credit Suisse | Buy Maintains $40 → $38 | Buy | Maintains | $40 → $38 | +204.24% | Mar 16, 2023 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 7, 2023 |
| Wells Fargo | Wells Fargo | Buy Initiates $27 | Buy | Initiates | $27 | +116.17% | Mar 7, 2023 |
| Credit Suisse | Credit Suisse | Buy Initiates $40 | Buy | Initiates | $40 | +220.26% | Mar 7, 2023 |
| Guggenheim | Guggenheim | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +156.20% | Mar 7, 2023 |
| B of A Securities | B of A Securities | Strong Buy Initiates $39 | Strong Buy | Initiates | $39 | +212.25% | Mar 7, 2023 |
| Stifel | Stifel | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +260.29% | Mar 7, 2023 |